Lombardelli Letizia, Logiodice Federica, Aguerre-Girr Maryse, Kullolli Ornela, Haller Herman, Casart Ysabel, Berrebi Alain, L'Faqihi-Olive Fatima-Ezzahra, Duplan Valérie, Romagnani Sergio, Maggi Enrico, Rukavina Daniel, Le Bouteiller Philippe, Piccinni Marie-Pierre
Department of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
INSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Clin Mol Allergy. 2016 Jan 21;14:1. doi: 10.1186/s12948-016-0039-y. eCollection 2016.
Trophoblast expressing paternal HLA-C antigens resemble a semiallograft, and could be rejected by maternal CD4+ T lymphocytes. We examined the possible role in human pregnancy of Th17 cells, known to be involved in allograft rejection and reported for this reason to be responsible for miscarriages. We also studied Th17/Th1 and Th17/Th2 cells never investigated before. We defined for the first time the role of different Th17 subpopulations at the embryo implantation site and the role of HLA-G5, produced by the trophoblast/embryo, on Th17 cell differentiation.
Cytokine production by CD4+ purified T cell and T clones from decidua of normal pregnancy, unexplained recurrent abortion, and ectopic pregnancy at both embryo implantation site and distant from that site were analyzed for protein and mRNA production. Antigen-specific T cell lines were derived in the presence and in the absence of HLA-G5.
We found an associated spontaneous production of IL-17A, IL-17F and IL-4 along with expression of CD161, CCR8 and CCR4 (Th2- and Th17-type markers) in fresh decidua CD4+ T cells during successful pregnancy. There was a prevalence of Th17/Th2 cells (producing IL-17A, IL-17F, IL-22 and IL-4) in the decidua of successful pregnancy, but the exclusive presence of Th17 (producing IL-17A, IL-17F, IL-22) and Th17/Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ) cells was found in the decidua of unexplained recurrent abortion. More importantly, we observed that Th17/Th2 cells were exclusively present at the embryo implantation site during tubal ectopic pregnancy, and that IL-4, GATA-3, IL-17A, ROR-C mRNA levels increased in tubal biopsies taken from embryo implantation sites, whereas Th17, Th17/Th1 and Th1 cells are exclusively present apart from implantation sites. Moreover, soluble HLA-G5 mediates the development of Th17/Th2 cells by increasing IL-4, IL-17A and IL-17F protein and mRNA production of CD4+ T helper cells.
No pathogenic role of decidual Th17 cells during pregnancy was observed. Indeed, a beneficial role for these cells was observed when they also produced IL-4. HLA-G5 could be the key feature of the uterine microenvironment responsible for the development of Th17/Th2 cells, which seem to be crucial for successful embryo implantation.
表达父系HLA - C抗原的滋养层细胞类似于半同种异体移植物,可能会被母体CD4 + T淋巴细胞排斥。我们研究了Th17细胞在人类妊娠中可能发挥的作用,已知Th17细胞参与同种异体移植物排斥反应,且有报道称其与流产有关。我们还研究了此前从未研究过的Th17/Th1和Th17/Th2细胞。我们首次明确了不同Th17亚群在胚胎着床部位的作用以及滋养层/胚胎产生的HLA - G5对Th17细胞分化的作用。
分析正常妊娠、不明原因复发性流产和异位妊娠患者蜕膜中CD4 + 纯化T细胞及T克隆在胚胎着床部位和远离该部位处产生细胞因子的蛋白质和mRNA水平。在有或无HLA - G5存在的情况下获得抗原特异性T细胞系。
我们发现,在成功妊娠期间,新鲜蜕膜CD4 + T细胞中自发产生IL - 17A、IL - 17F和IL - 4,并伴有CD161、CCR8和CCR4(Th2型和Th17型标志物)的表达。成功妊娠的蜕膜中Th17/Th2细胞(产生IL - 17A、IL - 17F、IL - 22和IL - 4)占优势,但在不明原因复发性流产的蜕膜中仅发现Th17细胞(产生IL - 17A、IL - 17F、IL - 22)和Th17/Th1细胞(产生IL - 17A、IL - 17F、IL - 22和IFN - γ)。更重要的是,我们观察到在输卵管异位妊娠时,Th17/Th2细胞仅存在于胚胎着床部位,且从胚胎着床部位获取的输卵管活检组织中IL - 4、GATA - 3、IL - 17A、ROR - C mRNA水平升高,而Th17、Th17/Th1和Th1细胞仅存在于着床部位以外。此外,可溶性HLA - G5通过增加CD4 + T辅助细胞的IL - 4、IL - 17A和IL - 17F蛋白质及mRNA产生来介导Th17/Th2细胞的发育。
未观察到蜕膜Th17细胞在妊娠期间具有致病作用。事实上,当这些细胞也产生IL - 4时,观察到它们具有有益作用。HLA - G5可能是子宫微环境中负责Th17/Th2细胞发育的关键特征,而Th17/Th2细胞似乎对胚胎成功着床至关重要。